Position in BMY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,881
-$1,340,783 QoQ
Shares Held
50
-99.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,469
of 2,506 holders
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Jun 30, 2026CallValue
$88,446
CallShares
1,535
PutValue
$48,573
PutShares
843
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Persistent Asset Partners Ltd holds $4,144,035 across 7 Drug Manufacturers - General names. BMY ranks #7 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,605 | $1,423,501 | |
| 2 | NVO |
Novo Nordisk A S
|
25,600 | $1,227,264 | |
| 3 | AZN |
Astrazeneca PLC
|
4,058 | $769,477 | |
| 4 | SNY |
Sanofi
|
14,750 | $629,235 | |
| 5 | LLY |
ELI LILLY & Co
|
56 | $67,168 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
194 | $24,509 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
50 | $2,881 |
All Filings in BMY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,446 | 1,535 | Call | Sole | 2026-08-07 | |
| 2026-06-30 | $2,881 | 50 | Shares | Sole | 2026-08-07 | |
| 2026-06-30 | $48,573 | 843 | Put | Sole | 2026-08-07 | |
| 2025-09-30 | $1,343,664 | 29,793 | Shares | Sole | 2026-01-15 | |
| No filing history on record for this holder in this stock. | ||||||